McNeil Consumer Healthcare wants Americans to enjoy ‘the great outdoors’
FORT WASHINGTON, Pa. McNeil Consumer Healthcare and the National Park Foundation on Monday announced a partnership designed to encourage everyone, including people with allergies, to pledge to spend more time enjoying outdoor moments with friends and family.
To kick off the campaign, Discovery Channel’s international explorer and wilderness survival expert, Josh Bernstein, set up camp at Floyd Bennett Field in Brooklyn, N.Y., on April 17, reminding people that spring is the perfect time to start enjoying the outdoors, and camping is a great way to do just that.
“We are proud to partner with the National Park Foundation to protect our parks and encourage everyone to visit these very special places,” stated Jorge Leon, Benadryl product director. “We understand that for people with allergies, enjoying time in one of America’s National Parks, or any outdoor destination, may take just a little more planning, but the outdoor moments you enjoy with friends and family make it worth it.”
As part of the partnership, McNeil is donating $200,000 to the NPF. In addition, until June 15, a $1 donation will be made each time someone visits www.BenadrylMoments.com and enters a unique promotion code found on specially marked packages of Benadryl. Consumers are also encouraged to visit www.BenadrylMoments.com where they can pledge to enjoy a moment outdoors.
Study finds that Mannatech supplement can improve vision, memory
COPPELL, Texas One tablespoon of a dietary supplement can improve mental functioning, a study indicates.
The study, by researchers at Howard University and published in the journal Perceptual & Motor Skills, indicated that a tablespoon of Mannatech’s supplement Ambrotose can “significantly improve” visual discrimination and working memory.
“The results of this study are impressive because they show significant improvement in the perceptual capabilities of healthy adults, which indicates that Ambrotose complex can benefit everyone,” researcher Atiya Stancil said.
Stancil and fellow researcher Leslie Hicks conducted the randomized, double-blind, placebo-controlled study on 62 healthy young adults.
WellSpring’s anti-nausea medication proves successful in market
SARASOTA, Fla, WellSpring Pharmaceutical on Tuesday announced that its anti-nausea liquid Emetrol is now the leading product in its category based on trailing 52-week sales ended Jan. 14, citing data from Information Resources Inc.
Over that 52-week period, Emetrol marketshare grew to 51.7% of the category based on sales growth of more than 24%.
WellSpring recently rolled out a national advertising campaign targeting women between the ages of 25 and 34, the company stated. And the National Association of Pediatric Nurse Practitioners recently selected Emetrol for editorial content in an upcoming issue.
“The fact that we are recommended by OB/GYN physicians for their patients experiencing nausea associated with pregnancy and by pediatricians for children under their care, has proven to be one of the most important attributes of the brand,” stated WellSpring president and CEO Robert Vukovich.